Geert Mannens

2.8k total citations
59 papers, 2.1k citations indexed

About

Geert Mannens is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Geert Mannens has authored 59 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Pharmacology and 11 papers in Oncology. Recurrent topics in Geert Mannens's work include Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). Geert Mannens is often cited by papers focused on Pharmacogenetics and Drug Metabolism (20 papers), Drug Transport and Resistance Mechanisms (6 papers) and Amino Acid Enzymes and Metabolism (4 papers). Geert Mannens collaborates with scholars based in Belgium, United States and United Kingdom. Geert Mannens's co-authors include W. Meuldermans, Jan Hendrickx, J Heykants, Filip Cuyckens, Pieter Annaert, Robert Woestenborghs, Minxue Huang, Hilde Bohets, Eric Snoeck and Marc Vermeir and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Geert Mannens

57 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geert Mannens Belgium 25 749 550 472 353 330 59 2.1k
Ji‐Hong Shon South Korea 27 833 1.1× 335 0.6× 501 1.1× 202 0.6× 318 1.0× 60 1.9k
Ulf Bredberg Sweden 21 352 0.5× 454 0.8× 621 1.3× 168 0.5× 159 0.5× 33 1.9k
Larry M. Tremaine United States 24 932 1.2× 319 0.6× 731 1.5× 140 0.4× 275 0.8× 48 1.8k
Kelem Kassahun United States 21 516 0.7× 590 1.1× 271 0.6× 260 0.7× 183 0.6× 41 1.7k
Su Duan United States 26 1.6k 2.1× 534 1.0× 761 1.6× 243 0.7× 458 1.4× 43 2.9k
Kamlesh P. Vyas United States 26 854 1.1× 606 1.1× 494 1.0× 98 0.3× 421 1.3× 58 2.3k
John M. Strong United States 30 546 0.7× 661 1.2× 580 1.2× 162 0.5× 253 0.8× 76 2.4k
J. H. G. Jonkman Netherlands 29 571 0.8× 382 0.7× 343 0.7× 217 0.6× 428 1.3× 115 2.4k
Dennis O. Scott United States 26 488 0.7× 638 1.2× 621 1.3× 87 0.2× 560 1.7× 51 2.1k
A Küpfer Switzerland 29 1.3k 1.7× 840 1.5× 663 1.4× 207 0.6× 310 0.9× 63 3.2k

Countries citing papers authored by Geert Mannens

Since Specialization
Citations

This map shows the geographic impact of Geert Mannens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geert Mannens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geert Mannens more than expected).

Fields of papers citing papers by Geert Mannens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geert Mannens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geert Mannens. The network helps show where Geert Mannens may publish in the future.

Co-authorship network of co-authors of Geert Mannens

This figure shows the co-authorship network connecting the top 25 collaborators of Geert Mannens. A scholar is included among the top collaborators of Geert Mannens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geert Mannens. Geert Mannens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laenen, Annouschka, Grayson Hough, Jan Snoeys, et al.. (2025). Absorption, distribution, metabolism, and excretion of an antiviral drug-Fc conjugate CD388 following subcutaneous administration of 14C-CD388 in the rat. Drug Metabolism and Disposition. 53(7). 100103–100103.
2.
T’jollyn, Huybrecht, Jan Snoeys, Jan Van Bocxlaer, et al.. (2016). Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro–In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound. European Journal of Drug Metabolism and Pharmacokinetics. 42(3). 537–543. 5 indexed citations
3.
4.
Acharya, Milin, Martha Gonzalez, Geert Mannens, et al.. (2012). A phase I, open-label, single-dose, mass balance study of 14C-labeled abiraterone acetate in healthy male subjects. Xenobiotica. 43(4). 379–389. 53 indexed citations
5.
Boussery, Koen, et al.. (2011). Evaluation of Three State-of-the-Art Metabolite Prediction Software Packages (Meteor, MetaSite, and StarDrop) through Independent and Synergistic Use. Drug Metabolism and Disposition. 39(11). 2066–2075. 31 indexed citations
6.
Bohets, Hilde, et al.. (2011). Clinical Pharmacology of Alcaftadine, a Novel Antihistamine for the Prevention of Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics. 27(2). 187–195. 23 indexed citations
7.
Vermeir, Marc, et al.. (2009). Absorption, Metabolism, and Excretion of Darunavir, a New Protease Inhibitor, Administered Alone and with Low-Dose Ritonavir in Healthy Subjects. Drug Metabolism and Disposition. 37(4). 809–820. 59 indexed citations
8.
Vermeir, Marc, Alex Hemeryck, Filip Cuyckens, et al.. (2009). In vitro studies on the metabolism of trabectedin (YONDELIS®) in monkey and man, including human CYP reaction phenotyping. Biochemical Pharmacology. 77(10). 1642–1654. 18 indexed citations
9.
Vermeir, Marc, Bart Remmerie, Geert Mannens, et al.. (2008). Absorption, Metabolism, and Excretion of Paliperidone, a New Monoaminergic Antagonist, in Humans. Drug Metabolism and Disposition. 36(4). 769–779. 133 indexed citations
10.
Mamidi, Rao N. V. S., Geert Mannens, Pieter Annaert, et al.. (2007). Metabolism and Excretion of RWJ-333369 [1,2-Ethanediol, 1-(2-Chlorophenyl)-, 2-carbamate, (S)-] in Mice, Rats, Rabbits, and Dogs. Drug Metabolism and Disposition. 35(4). 566–575. 12 indexed citations
11.
Mannens, Geert, Jan Hendrickx, Shuchean Chien, et al.. (2006). The Absorption, Metabolism, and Excretion of the Novel Neuromodulator RWJ-333369 (1,2-Ethanediol, [1-2-Chlorophenyl]-, 2-carbamate, [ S ]-) in Humans. Drug Metabolism and Disposition. 35(4). 554–565. 35 indexed citations
12.
Roymans, Dirk, Pieter Annaert, Jos Van Houdt, et al.. (2005). EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES. Drug Metabolism and Disposition. 33(7). 1004–1016. 56 indexed citations
13.
Annaert, Pieter, et al.. (2005). In vitro study on transepithelial transport of the psychotropic compound paliperidone (PAL) across Caco-2 monolayers. Drug Metabolism Reviews. 37. 15–15. 3 indexed citations
14.
Angibaud, Patrick, Ashis Saha, David W. End, et al.. (2003). 4-Methyl-1,2,4-triazol-3-yl heterocycle as an alternative to the 1-methylimidazol-5-yl moiety in the Farnesyltransferase inhibitor ZARNESTRA ™. Bioorganic & Medicinal Chemistry Letters. 13(24). 4361–4364. 13 indexed citations
15.
Roymans, Dirk, Angelique M. Leone, J. Brandon Parker, et al.. (2003). Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes. Biochemical Pharmacology. 67(3). 427–437. 57 indexed citations
16.
17.
Ducharme, Murray P., Richard L. Slaughter, L H Warbasse, et al.. (1995). Itraconazole and hydroxyitraconazole serum concentrations are reduced more than tenfold by phenytoin*. Clinical Pharmacology & Therapeutics. 58(6). 617–624. 51 indexed citations
18.
Mannens, Geert, Minxue Huang, W. Meuldermans, et al.. (1993). Absorption, metabolism, and excretion of risperidone in humans.. Drug Metabolism and Disposition. 21(6). 1134–1141. 225 indexed citations
19.
Mannens, Geert, et al.. (1990). Assay for acetyl-CoA: arylamine N-acetyltransferase by high-performance liquid chromatography applied to serotonin N-acetylation. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1037(1). 1–6. 5 indexed citations
20.
Slegers, Guido, et al.. (1986). Enzymatic synthesis of 13 N-labeled γ-amino-butyric acid. Journal of Labelled Compounds and Radiopharmaceuticals. 23. 1114–1115. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ji‐Hong Shon Breakdown of academic impact, for papers by Ulf Bredberg Breakdown of academic impact, for papers by Larry M. Tremaine Breakdown of academic impact, for papers by Kelem Kassahun Breakdown of academic impact, for papers by Su Duan Breakdown of academic impact, for papers by Kamlesh P. Vyas Breakdown of academic impact, for papers by John M. Strong Breakdown of academic impact, for papers by J. H. G. Jonkman Breakdown of academic impact, for papers by Dennis O. Scott Breakdown of academic impact, for papers by A Küpfer
Rankless by CCL
2026